Summation
- Earlier in her career, she served as a Program Manager with the University of Oklahoma and a Child Welfare Specialist with the Oklahoma Department of Human Services.
- DM Clinical Research has hired industry veteran Stephanie Ailey as Vice President of Business Development, bringing more than 20 years of program management and healthcare experience to the national clinical trial site network.
- “I love research and had the unique experience of working at the study site that enrolled the first patient globally to participate in a Phase 3 COVID-19 trial,” said Ailey.
DM Clinical Research has hired industry veteran Stephanie Ailey as Vice President of Business Development, bringing more than 20 years of program management and healthcare experience to the national clinical trial site network.
“Stephanie has a great track record building strategic relationships that help advance medical research,” said Mohammad Millwala, CEO & Founder of DM Clinical Research. “Our site network has been growing rapidly over the last three years and Stephanie will be an important part of our success going forward. DM Clinical Research expects to launch several new sites before the end of the year and Stephanie’s expertise will be vital to ensuring success as we enter new markets.”
Stephanie Ailey previously served as Vice President of Business Development with both Velocity Clinical Research and Meridian Clinical Research. She also served as Meridian’s Senior Director of Business Development, Director of Business Development, and Director of Operations.
“I love research and had the unique experience of working at the study site that enrolled the first patient globally to participate in a Phase 3 COVID-19 trial,” said Ailey. “I was attracted to DM Clinical Research because of Mohammad and his vision for the company. The commitment Mohammad has shown to not only diversity in clinical trials, but diversity among the staff and primary investigators is inspirational.”
While many study sites and clinical research sponsors continue to struggle to ensure diversity, 48.5% of all participants in DM Clinical Research studies in 2022 identified as diverse. In 2022, the company reported minority enrollment of 50.41% in vaccine studies. DM Clinical Research’s leadership team and employees are also extremely diverse with roughly 75 percent of the company’s more than 600 employees identifying as diverse.
Originally from Oklahoma, Ailey now resides in Savannah, Georgia. Earlier in her career, she served as a Program Manager with the University of Oklahoma and a Child Welfare Specialist with the Oklahoma Department of Human Services. Ailey received a Citation of Appreciation from the Oklahoma State Legislature in recognition of her volunteer work. She earned a Bachelor’s in Communication from Southwestern Adventist University.
